The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?
Open accessAbstract
Together with aspartate, glutamate is the major excitatory neurotransmitter in the brain. Glutamate binds and activates both ligand-gated ion channels (ionotropic glutamate receptors) and a class of G-protein coupled receptors (metabotropic glutamate receptors). Although the intracellular glutamate concentration in the brain is in the millimolar range, the extracellular glutamate concentration is kept in the low micromolar range by the action of excitatory amino acid transporters that import glutamate and aspartate into astrocytes and neurons. Excess extracellular glutamate may lead to excitotoxicity in vitro and in vivo in acute insults like ischemic stroke via the overactivation of ionotropic glutamate receptors. In addition, chronic excitotoxicity has been hypothesized to play a role in numerous neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer's disease and Huntington's disease. Based on this hypothesis, a good deal of effort has been devoted to develop and test drugs that either inhibit glutamate receptors or decrease extracellular glutamate. In this review, we provide an overview of the different pathways that are thought to lead to an over-activation of the glutamatergic system and glutamate toxicity in neurodegeneration. In addition, we summarize the available experimental evidence for glutamate toxicity in animal models of neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–238 of 238
Pathophysiology of neurodegeneration following traumatic brain injury.
Freire, M. A. M. (2012) · PubMed · Cited by 72
CSF excitatory amino acids and severity of illness in Alzheimer's disease
Csernansky, J. G., Bardgett, M. E., Sheline, Y. I., Morris, J. C., & Olney, J. W. (1996) · Neurology · doi:10.1212/wnl.46.6.1715 · Cited by 72
Kaiser, E., Schoenknecht, P., Kassner, S. S., Hildebrandt, W., Kinscherf, R., & Schröeder, J. (2010) · Neurodegenerative Diseases · doi:10.1159/000287953 · Cited by 71
Emnett, C. M., Eisenman, L. N., Taylor, A. M., Izumi, Y., Zorumski, C. F., & Mennerick, S. J. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.089334 · Cited by 69
Hansson, O., Castilho, R. F., Korhonen, L., Lindholm, D., Bates, G. P., & Brundin, P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00482.x · Cited by 64
Kuiper, M. A., Teerlink, T., Visser, J. J., Bergmans, P., Scheltens, P., & Wolters, E. C. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050016 · Cited by 64
Fuchs, A., Kutterer, S., Mühling, T., Duda, J., Schütz, B., Liss, B., Keller, B. U., & Roeper, J. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.247981 · Cited by 63
Alexander, G. M., Deitch, J. S., Seeburger, J. L., Valle, L. D., & Heiman-Patterson, T. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741666.x · Cited by 58
β-Amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3
Deng, Y., Zhe, X., Chen, P., Wei, J., Chen, S., & Yan, Z. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.031 · Cited by 58
Loss, C. M., Córdova, S. D., & de Oliveira, D. L. (2012) · Brain Research · doi:10.1016/j.brainres.2012.07.046 · Cited by 55
Grilli, M., Diodato, E., Lozza, G., Brusa, R., Casarini, M. J., Uberti, D. L., Rozmahel, R. F., Westaway, D. A., George‐Hyslop, P. S., Memo, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12822 · Cited by 52
Xing, X., Chang, L., Kong, Q., Colton, C. K., Lai, L., Glicksman, M. A., Lin, C. G., & Cuny, G. D. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.009 · Cited by 52
Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction
Kiryk, A., Aida, T., Tanaka, K., Banerjee, P., Wilczynski, G. M., Meyza, K. Z., Knapska, E., Filipkowski, R. K., Kaczmarek, L., & Danysz, W. (2008) · Neurotoxicity Research · doi:10.1007/bf03033364 · Cited by 51
Petr, G. T., Schultheis, L. A., Hussey, K. C., Sun, Y., Dubinsky, J. M., Aoki, C. J., & Rosenberg, P. A. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12202 · Cited by 51
Metabotropic Glutamate Receptors: Their Therapeutic Potential in Anxiety
Spooren, W. P. J. M., Lesage, A., Lavreysen, H., Gasparini, F., & Steckler, T. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_36 · Cited by 49
Backpropagating Action Potentials Enable Detection of Extrasynaptic Glutamate by NMDA Receptors
Wu, Y., Grebenyuk, S. E., McHugh, T. J., Rusakov, D. A., & Semyanov, A. V. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.03.007 · Cited by 49
Petersén, Å., Hansson, O., Puschban, Z., Sapp, E., Romero, N. B., Castilho, R. F., Sulzer, D., Rice, M. E., DiFiglia, M., Przedborski, S., et al. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01765.x · Cited by 44
Fontana, A. C. K., Fox, D. P., Zoubroulis, A., Mortensen, O. V., & Raghupathi, R. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2015.4079 · Cited by 44
Qiu, S., Pak, C. W., & Currás‐Collazo, M. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfj008 · Cited by 44
Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate
Wang, X., Bao, X., Pal, R., Aǵbaş, A., & Michaelis, E. K. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-360 · Cited by 43
Takeda, K., Ishida, A., Takahashi, K., & Ueda, T. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07684.x · Cited by 42
Holopainen, I. E., & KONTRO, P. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490240306 · Cited by 42
Kilpatrick, I. C., & Mozley, L. S. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90078-9 · Cited by 42
Neuroprotective effects of MK-801 against traumatic brain injury in immature rats
Sönmez, A., Sayın, O., Gürgen, S. G., & Çalışır, M. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.05.001 · Cited by 40
Mazarei, G., Budac, D. P., Lu, G., Lee, H., Möller, T., & Leavitt, B. R. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.08.007 · Cited by 39
Urenjak, J., & Obrenovitch, T. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752427.x · Cited by 37
Chronic glutamate toxicity in mouse cortical neuron culture
Ha, J. S., Lee, C.-S., Maeng, J., Kwon, K., & Park, S. S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.050 · Cited by 36
Age‐dependent alterations of the kynurenine pathway in the YAC 128 mouse model of Huntington disease
Mazarei, G., Budac, D. P., Lu, G., Adomat, H. H., Guns, E. S. T., Möller, T., & Leavitt, B. R. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12350 · Cited by 36
Hayes, D., Wießner, M., Rauen, T., & McBean, G. J. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.03.001 · Cited by 34
Yamamoto, S., Morinobu, S., Iwamoto, Y., Ueda, Y., Takei, S., Fujita, Y., & Yamawaki, S. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.03.013 · Cited by 33
Thompson, M. M., Marecki, J. C., Marinesco, S., Labrie, V., Roder, J., Barger, S. W., & Crow, J. P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07601.x · Cited by 32
Roles of the nucleolus in the CAG RNA-mediated toxicity
Tsoi, H., & Chan, H. Y. E. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.11.015 · Cited by 30
Frederick, N. M., Bertho, J., Patel, K. K., Petr, G. T., Bakradze, E., Smith, S. B., & Rosenberg, P. A. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.06.017 · Cited by 28
Regulation of system xc− in the SOD1-G93A mouse model of ALS
Albano, R., Liu, X., & Lobner, D. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.09.008 · Cited by 23
Questioning on the role of D amino acid oxidase in familial amyotrophic lateral sclerosis
Millecamps, S., da Barroca, S., Cazeneuve, C., Salachas, F., Pradat, P., Danel-Brunaud, V., Vandenberghe, N., Lacomblez, L., Forestier, N. L., Bruneteau, G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006190107 · Cited by 21
Brunet, N., Tarabal, O., Esquerda, J. E., & Calderó, J. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22118 · Cited by 21
Yuzaki, M., & Connor, J. A. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.5.2820 · Cited by 20
Schomburg, D., & Stephan, D. (1994) · Springer eBooks · doi:10.1007/978-3-642-57942-4_91 · Cited by 2
Cited by
Dysregulation of brain and choroid plexus cell types in severe COVID-19
Yang, A. C., Kern, F., Losada, P. M., Agam, M. R., Maat, C. A., Schmartz, G. P., Fehlmann, T., Stein, J. A., Schaum, N., Lee, D. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03710-0 · Cited by 620
Inflammation, glutamate, and glia: a trio of trouble in mood disorders
Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584
The role of zinc, copper, manganese and iron in neurodegenerative diseases
Mezzaroba, L., Alfieri, D. F., Colado Simão, A. N., & Vissoci Reiche, E. M. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.07.007 · Cited by 524
Costa, L. G., Cole, T. B., Dao, K., Chang, Y.-C., Coburn, J., & Garrick, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107523 · Cited by 484
Tagge, C. A., Fisher, A. M., Minaeva, O. V., Gaudreau-Balderrama, A., Moncaster, J. A., Zhang, X.-L., Wojnarowicz, M. W., Casey, N., Lu, H., Kokiko-Cochran, O. N., et al. (2018) · Brain · doi:10.1093/brain/awx350 · Cited by 383
Metadata
- Authors
- Lewerenz, J., & Maher, P.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2015-12-16
- Volume
- 9
- Pages
- 469-469
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2212369426
- Cited by
- 718
- References
- 238
- FWCI
- 18.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.